Medicine News

Experimental Compound Improves Learning and Memory in Mice with Down Syndrome

September 5, 2013

0 Comments

Compound Reverses Down Syndrome Like Learning Deficits in Mice

In a newly published study, scientists detail the development of an experimental compound that reverses Down syndrome-like learning deficits in mice. Researchers at Johns Hopkins and the National Institutes of Health have identified a compound that dramatically bolsters learning and memory when given to mice with a Down syndrome-like condition on the day of birth. […]

Continue reading...

Drug Candidate SR9009 Increases Exercise Endurance

August 21, 2013

2 Comments

Drug Candidate Leads to Improved Endurance

A new drug candidate, SR9009, has been shown to significantly increase exercise endurance in animal models. Researchers believe these findings may lead to better treatments for people suffering from conditions that acutely limit exercise tolerance. An international group of scientists has shown that a drug candidate designed by scientists from the Florida campus of The […]

Continue reading...

Newly Discovered Small Molecule Inhibitor Boosts Insulin Signaling

August 14, 2013

1 Comment

Newly Discovered Small Molecule Boosts Insulin Signaling

Harvard Medical School researchers have uncovered a new pathway in insulin resistance and show that a newly discovered small-molecule inhibitor can interrupt this pathway and increase insulin signaling. Insulin resistance unleashes a vicious cycle in Type 2 diabetes whereby excess blood sugar induces the release of yet more insulin by the pancreas. A primary goal […]

Continue reading...

Deltarasin Blocks Oncogenic Protein KRAS, Opens Up New Approaches to Cancer Therapy

August 8, 2013

1 Comment

Deltarasin Blocks the Oncogenic Protein KRAS

Scientists at the Max Planck Institute have discovered how Deltarasin prevents the transport of the oncogenic protein KRAS to the cell membrane, opening up new approaches to cancer therapy treatment. One of the major goals in the development of anti-cancer treatments is to find an inhibitor effective against the oncogenic protein known as KRAS. Despite […]

Continue reading...

“Personalized” Tumor Vaccine Works on Hard-to-Treat Leukemia


August 7, 2013

0 Comments

New Vaccine Works on Hard to Treat Leukemia


In a newly published study, researchers observed a strong and selective immune response in some patients who received, shortly after the transplant, several doses of a “personalized” tumor vaccine composed of their own inactivated leukemia cells combined with an immune stimulant. Patients with advanced chronic lymphocytic leukemia (CLL) often receive donor transplants that effectively “reboot” […]

Continue reading...

Newly Discovered Protein Offers Vast Potential for Cancer Treatment

July 31, 2013

0 Comments

Newly Discovered Protein Offers Potential for Treatment of Cancer

An international team of researchers has discovered a new protein called ceramide-1 phosphate transport protein (CPTP) that has the potential to aid in the treatment of cancer and other diseases. In cancer research, discovering a new protein that plays a role in cancer is like finding a key and a treasure map: follow the clues […]

Continue reading...

Yale Study Shows No Link between Hospital Readmissions and Death Rates

February 18, 2013

0 Comments

No Link Between Hospital Readmissions and Death Rates

New research from Yale University shows that many health institutions do well on mortality and readmission and that performance on one does not dictate performance on the other. Hospital performance on two Medicare quality measures are not strongly related, and are likely to reflect very different aspects of their clinical care, according to results published […]

Continue reading...

Beer’s Bitter Compounds May Result in New Treatments for Diabetes and Other Maladies

January 30, 2013

0 Comments

Humulone Molecule

Using a process called X-ray crystallography, scientists at the University of Washington have determined the precise configuration of humulones, which may result in new pharmaceuticals to treat diabetes, some types of cancer and other maladies. Researchers employing a century-old observational technique have determined the precise configuration of humulones, substances derived from hops that give beer […]

Continue reading...

Highly Recurrent Mutations Discovered in “Dark Matter” of the Cancer Genome

January 29, 2013

0 Comments

A Human Melanoma Cell

Two newly discovered TERT promoter mutations were found to be even more common than BRAF mutations in melanoma, collectively occurring in 71% of the melanomas examined. Two mutations that collectively occur in 71 percent of malignant melanoma tumors have been discovered in what scientists call the “dark matter” of the cancer genome, where cancer-related mutations […]

Continue reading...

Regular Aspirin Use Linked to Age-Related Macular Degeneration

January 28, 2013

0 Comments

Aspirin Use Increases the Risk of Age Related Eye Disease

A new study found that regular aspirin use is significantly associated with an increased incidence of neovascular AMD, a leading cause of blindness in older people. Researchers at the Center for Vision Research from the Westmead Millennium Institute for Medical Research (WMI), a close affiliate of the University of Sydney, have found that regular aspirin […]

Continue reading...

Stem Cells Help Restore a Man’s Vision

December 26, 2012

1 Comment

Doctors at Toronto Western Hospital preform a stem cell transplant to help a patient regain their sight. Credit: CTV News

Taylor Binns began slowly going blind because of complications with his contact lenses. However, an innovative treatment using stem cells has allowed him to regain his sight. While on humanitarian work in Haiti, Binns developed intense eye pain and increasingly blurry vision. Over the next two years, Binns slowly went legally blind, with his doctors […]

Continue reading...

Radiation Exposure Could Be Countered By Ingesting Ex-Rad Pills

December 11, 2012

3 Comments

nuclear-bomb

The US Department of Defense has been developing pills that will protect humans from radiation. The pills are named Ex-Rad and were developed by Onconova Therapeutics in conjunction with the DoD. The scientists published their findings in the journal Radiation Research. Once humans have been exposed to radiation, there hasn’t been much they could do […]

Continue reading...